C-MER Eye Care Holdings Limited (HK:3309)
:3309
Want to see HK:3309 full AI Analyst Report?
3309 Stock Chart & Stats
HK$1.70
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$1.70
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$1.00 - HK$2.16
Previous CloseN/A
Volume360.00K
Average Volume (3M)495.46K
Market Cap
HK$1.26B
Enterprise ValueHK$1.34B
Total Cash (Recent Filing)HK$465.96M
Total Debt (Recent Filing)HK$426.78M
Price to Earnings (P/E)12.2
Beta1.11
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.2%
Share Statistics
EPS (TTM)0.08
Shares Outstanding1,232,342,900
10 Day Avg. Volume419,185
30 Day Avg. Volume495,465
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)1.17
Price to Sales (P/S)1.07
P/FCF Ratio9.26
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistently positive operating cash flow and multi-year free cash flow strength provide durable internal funding for operations, selective clinic expansion and capex. This reduces reliance on external financing, lowering refinancing risk and supporting resilience through patient-volume cycles.
Moderate, Manageable LeverageA low-to-moderate debt profile preserves financial flexibility for capital-intensive medical services. Manageable leverage supports investment in facilities and equipment, reduces interest burdens, and gives the company capacity to absorb temporary earnings swings without compromising solvency.
Sustained Revenue Expansion And Margin RecoveryMulti-year revenue growth and a return to positive net income with solid operating margins indicate underlying demand and operational leverage. If sustained, this trend supports scalable profitability, improved cash conversion and the ability to invest in service quality and network growth over the medium term.
Bears Say
Earnings VolatilityRepeated swings into losses undermine predictability of free cash available for reinvestment or distributions. For a fee-for-service medical network, volatile earnings complicate medium-term planning for staffing, capacity and capex and increase execution risk when scaling services.
Inconsistent Shareholder ReturnsUneven returns reflect fragile ability to sustain ROE and consistent profitability. This makes it harder to justify stable distributions or predictable buybacks and can weigh on long-term investor confidence, particularly if sensitivity to case mix and utilization persists.
Free Cash Flow And Conversion VolatilityAlthough absolute free cash flow is strong, volatility and missing/zero coverage metrics limit confidence in reliable cash conversion. This hampers dependable forecasts for capex, dividend policy and debt servicing, raising execution risk for longer-term strategic investments.
C-MER Eye Care Holdings Limited News
3309 FAQ
What was C-MER Eye Care Holdings Limited’s price range in the past 12 months?
C-MER Eye Care Holdings Limited lowest stock price was HK$1.00 and its highest was HK$2.16 in the past 12 months.
What is C-MER Eye Care Holdings Limited’s market cap?
C-MER Eye Care Holdings Limited’s market cap is HK$1.26B.
When is C-MER Eye Care Holdings Limited’s upcoming earnings report date?
C-MER Eye Care Holdings Limited’s upcoming earnings report date is Sep 01, 2026 which is in 82 days.
How were C-MER Eye Care Holdings Limited’s earnings last quarter?
C-MER Eye Care Holdings Limited released its earnings results on Mar 27, 2026. The company reported HK$0.042 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.042.
Is C-MER Eye Care Holdings Limited overvalued?
According to Wall Street analysts C-MER Eye Care Holdings Limited’s price is currently Overvalued.
Does C-MER Eye Care Holdings Limited pay dividends?
C-MER Eye Care Holdings Limited pays a Annually dividend of HK$0.03 which represents an annual dividend yield of 1.2%. See more information on C-MER Eye Care Holdings Limited dividends here
What is C-MER Eye Care Holdings Limited’s EPS estimate?
C-MER Eye Care Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does C-MER Eye Care Holdings Limited have?
C-MER Eye Care Holdings Limited has 1,232,342,900 shares outstanding.
What happened to C-MER Eye Care Holdings Limited’s price movement after its last earnings report?
C-MER Eye Care Holdings Limited reported an EPS of HK$0.042 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.6%.
Which hedge fund is a major shareholder of C-MER Eye Care Holdings Limited?
Currently, no hedge funds are holding shares in HK:3309
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
C-MER Eye Care Holdings Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.66%
12-Months-Change
Fundamentals
Return on Equity
5.64%
Trailing 12-Months
Asset Growth
0.46%
Trailing 12-Months
Company Description
C-MER Eye Care Holdings Limited
C-MER Medical Holdings Limited specializes in offering both medical treatments and therapeutic services for a variety of eye conditions. Its business activities are segmented into two primary areas: the delivery of ophthalmological services and the retail of vision-enhancing products. Established by Shun Chiu Lam on February 1, 2016, the organization's corporate headquarters are situated in Hong Kong.
Technical Analysis
Rici Healthcare Holdings Ltd.
―
EuroEyes International Eye Clinic Limited
―
Chaoju Eye Care Holdings Ltd.
―
Guangdong Kanghua Healthcare Co., Ltd. Class H
―
Town Health International Medical Group Ltd.
―
Options Prices
Currently, No data available
---